Why compounding was ever legal
Compounding pharmacies are allowed to make copies of an FDA-approved drug only while that drug is officially in shortage. When Wegovy and Ozempic demand exploded in 2022, the FDA placed semaglutide on the drug shortage list — and licensed 503A pharmacies and 503B outsourcing facilities could legally produce compounded versions. That window created the $150–$400/month market millions of patients used.
What changed
In early 2025 the FDA declared the semaglutide shortage resolved (tirzepatide came off the list in late 2024). Grace periods followed — smaller 503A pharmacies had until spring 2025, larger 503B facilities until May 2025 — after which producing copies of semaglutide became illegal. Courts sided with the FDA when compounding trade groups challenged the decision, and enforcement letters followed for pharmacies and telehealth sellers that kept going.
Mass-produced compounded semaglutide and tirzepatide are no longer legal. Compounding survives only for genuinely individualized prescriptions — a documented medical reason the approved product cannot serve a specific patient (an allergy to an inactive ingredient, a dose the branded pens do not offer). Price and convenience do not qualify.
Red flags in 2026
- Flat-rate "compounded semaglutide" offered to every patient with no individualized justification
- No prescription required, or a questionnaire-only "consult" with no licensed prescriber
- "Research use only" peptide vials — these are unapproved drugs from unregulated sources
- Products shipped from overseas or sellers that will not name their pharmacy
- Added ingredients (B12, L-carnitine) used mainly to justify the compounding
Legal ways to pay less
| Option | Typical cost |
|---|---|
| NovoCare cash-pay (Wegovy) | ~$499 / month |
| LillyDirect Zepbound vials | $349–$499 / month |
| Manufacturer savings cards (eligible commercial insurance) | As low as $25 / month |
| Insurance with prior authorization | $0–$100 / month copay |
These manufacturer programs launched specifically to absorb former compounding patients — and for tirzepatide, LillyDirect vials often beat what compounded versions used to cost. If insurance denies coverage, read our guide to appealing a GLP-1 denial.
Frequently asked questions
Is compounded semaglutide legal in 2026?
Mostly no. Mass compounding was only legal while branded semaglutide was on the FDA shortage list. The FDA declared that shortage resolved in early 2025, and after grace periods expired, 503A pharmacies (spring 2025) and 503B outsourcing facilities (May 2025) had to stop producing copies. Narrow exceptions remain for genuinely individualized prescriptions — a specific dose or ingredient change a patient medically needs that the branded product cannot provide.
Can my clinic still sell me compounded semaglutide?
Only in limited cases. A clinic working with a state-licensed compounding pharmacy can dispense a compounded version when your prescriber documents a real clinical reason the FDA-approved product does not work for you — not price, and not convenience. If a clinic offers compounded semaglutide to every patient at a flat monthly rate with no individualized justification, that is the pattern FDA enforcement targets.
What happens if I buy semaglutide online without a prescription?
You are buying an unapproved drug from an unregulated source. "Research use only" peptide sites and gray-market telehealth operations skip the prescription requirement by breaking the law, and independent testing of seized products has repeatedly found wrong doses, impurities, and in some cases no semaglutide at all. Beyond the health risk, you have no pharmacist, no sterility assurance, and no recourse.
What are the cheapest legal alternatives to compounded semaglutide?
Manufacturer cash-pay programs replaced most of the compounded market: NovoCare sells Wegovy at roughly $499/month, and LillyDirect sells Zepbound vials at $349–$499/month — often less than compounded tirzepatide cost at its peak. Insurance coverage, manufacturer savings cards ($25/month for eligible commercial plans), and Medicare coverage of Wegovy for cardiovascular risk round out the legitimate options.
How do I know if a pharmacy or clinic is legitimate?
Check that the pharmacy is state-licensed (every state board of pharmacy has a public lookup), that a real prescriber evaluates you before any medication is offered, and that the product dispensed is either FDA-approved or compounded under a documented individual need. Walk away from anyone selling "semaglutide" without requiring a prescription, or shipping from overseas.
Related reading
Educational content, not legal or medical advice. Regulations continue to evolve — confirm current rules with your provider and pharmacy. GLPFinders does not prescribe, sell, or dispense medications.